MarketFriction

Shree Pacetronix Ltd

BSE 527005 · Medical Equipment & Supplies
₹185.00 +0.00%
BSE close2026-10-01
Market cap₹71.2 Cr.
P/E22.0

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales5.234.306.654.854.043.634.285.346.594.335.374.90
Expenses4.083.454.234.073.633.493.304.184.583.903.743.71
Operating Profit1.150.852.420.780.410.140.981.162.010.431.631.19
OPM %21.99%19.77%36.39%16.08%10.15%3.86%22.90%21.72%30.50%9.93%30.35%24.29%
Other Income0.020.030.050.050.020.020.030.020.030.020.050.03
Interest0.110.100.090.120.160.150.150.120.100.130.060.03
Depreciation0.200.220.360.210.210.170.210.170.190.170.210.17
Profit before tax0.860.562.020.500.06-0.160.650.891.750.151.411.02
Tax %22.09%28.57%28.71%28.00%33.33%-31.25%29.23%24.72%25.14%66.67%21.28%25.49%
Net Profit0.670.401.430.370.03-0.110.450.661.310.061.110.76
EPS in Rs1.861.113.971.030.08-0.311.251.833.640.162.962.03
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7.446.946.807.288.777.569.2320.2622.0416.6821.6421.19
Expenses6.376.395.886.507.576.627.4514.8116.1614.3416.4015.93
Operating Profit1.070.550.920.781.200.941.785.455.882.345.245.26
OPM %14.38%7.93%13.53%10.71%13.68%12.43%19.28%26.90%26.68%14.03%24.21%24.82%
Other Income0.020.050.010.170.040.050.070.100.140.120.120.13
Interest0.370.400.320.320.380.350.290.300.450.610.410.32
Depreciation0.770.650.420.380.510.510.500.630.950.810.740.74
Profit before tax-0.05-0.450.190.250.350.131.064.624.621.044.214.33
Tax %60.00%-26.67%31.58%44.00%31.43%61.54%26.42%29.44%27.49%27.88%25.42%
Net Profit-0.09-0.320.130.140.240.050.783.263.360.753.143.24
EPS in Rs-0.25-0.890.360.390.670.142.179.069.332.088.378.79
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth11%23%2%23%
Compounded Profit Growth43%129%-1%215%
Stock Price CAGR33%75%-21%-16%
Return on Equity14%21%18%20%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital3.603.603.603.603.603.603.603.603.603.603.603.75
Reserves1.771.681.361.601.741.982.032.816.079.4310.1814.36
Borrowings2.781.972.712.933.913.333.203.052.194.305.082.68
Other Liabilities0.951.351.161.331.352.082.152.724.684.424.194.92
Total Liabilities9.108.608.839.4610.6010.9910.9812.1816.5421.7523.0525.71
Fixed Assets3.132.552.021.882.402.472.692.563.124.243.873.81
CWIP0.000.000.770.991.251.811.641.651.660.930.930.93
Investments0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets5.976.056.046.596.956.716.657.9711.7616.5818.2520.97
Total Assets9.108.608.839.4610.6010.9910.9812.1816.5421.7523.0525.71
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0.471.350.421.130.312.251.091.761.69-0.04-0.012.92
Cash from Investing Activity-0.49-0.18-0.86-0.52-1.01-1.00-0.53-1.19-1.41-1.67-0.04-0.78
Cash from Financing Activity0.20-1.140.22-0.500.36-1.17-0.31-0.45-1.101.750.19-1.61
Net Cash Flow0.180.03-0.220.10-0.340.080.250.12-0.820.040.140.54
Free Cash Flow-0.021.15-0.460.63-0.721.130.531.420.49-1.38-0.731.69
CFO/OP54%126%98%123%45%192%135%106%48%19%47%73%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days70.9988.31113.08143.32152.92134.01145.81127.7384.8577.17145.08179.46
Inventory Days670.58359.32243.33301.93276.44216.62272.02194.20157.41285.83463.17275.46
Days Payable29.7132.6718.8649.6537.1054.1548.5717.5532.2212.4557.3260.45
Cash Conversion Cycle711.86414.96337.55395.60392.26296.48369.25304.38210.04350.55550.93394.47
Working Capital Days107.01116.27110.97107.35100.2742.8737.6623.3363.06101.68157.77180.14
ROCE %3.56%4.16%-0.80%6.46%5.06%7.93%5.30%14.43%46.15%34.74%9.12%23.30%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters24.25%24.25%24.25%24.25%24.25%24.25%24.25%24.25%24.25%25.80%31.70%36.44%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.14%0.14%0.00%0.00%
Public75.76%75.76%75.76%75.76%75.75%75.76%75.75%75.76%75.61%74.06%68.30%63.56%
No. of Shareholders5,8966,2076,5806,6896,9927,0486,9816,9726,6656,5296,5676,615

Fundamentals

Market Cap₹ 71.2 Cr.
Current Price₹ 190
Stock P/E22.0
Book Value₹ 48.3
ROCE23.3 %
ROE19.7 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)23%
Compounded Profit Growth (TTM)215%
Consolidated figures.
Valuation
Market capRs 69 Cr
Enterprise valueRs 70 Cr
P/E (TTM)21.41x
Price to book3.83x
Price to sales3.27x
EV / EBITDA13.05x
EV / EBIT15.13x
EV / sales3.32x
Price to cash flow23.76x
Earnings yield4.67%
P/E, 3-year average23.08x
P/B, 3-year average2.91x
P/E, 5-year average16.58x
P/B, 5-year average2.65x
Profitability
Operating margin (excl. other income)24.21%
Operating margin (incl. other income)24.77%
EBITDA margin25.44%
Pre-tax margin20.43%
Net profit margin15.29%
Net margin, latest quarter15.51%
ROE19.69%
ROCE23.30%
ROA12.88%
ROE, 3-year average18.30%
ROCE, 3-year average22.39%
ROA, 3-year average11.26%
ROE, 5-year average21.68%
ROCE, 5-year average25.62%
ROA, 5-year average12.64%
ROIC (approx.)18.18%
Tax rate25.42%
Other income / net worth0.66%
Growth
Sales growth (latest year)29.74%
Profit growth (latest year)318.67%
Sales CAGR, 3 years2.22%
Sales CAGR, 5 years23.41%
Profit CAGR, 3 years-1.24%
Profit CAGR, 5 years128.87%
Sales growth QoQ-8.75%
Profit growth QoQ-31.53%
Sales growth YoY (latest quarter)-8.24%
Profit growth YoY (latest quarter)15.15%
Per share
EPS (TTM)Rs 8.64
EPS (latest quarter)Rs 2.03
EPS, 3-year averageRs 5.71
EPS, 5-year averageRs 5.66
Book value per shareRs 48.30
Sales per shareRs 56.51
Cash flow per shareRs 7.79
Free cash flow per shareRs 4.51
Efficiency
Asset turnover0.84x
Fixed asset turnover5.68x
Inventory turnover1.33x
Inventory days275 days
Debtor days179 days
Debtors turnover2.03x
Creditor days60 days
Cash conversion cycle394 days
Working capital days180 days
Leverage
Total debtRs 3 Cr
Cash and bankRs 2 Cr
Net debtRs 1 Cr
Debt to equity0.15x
Net debt / EBITDA0.18x
Interest coverage14.53x
Owners' fund to total sources70.44%
Debt to assets10.42%
Cash flow
Cash from Operating Activity (latest year)Rs 3 Cr
Cash from Investing Activity (latest year)Rs -1 Cr
Cash from Financing Activity (latest year)Rs -2 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs 2 Cr
FCFE (approx.: FCF + change in debt)Rs -1 Cr
Cash from ops / profit, 5 years0.56x
Sales to cash flow7.41x
Statement figures
Net sales (TTM)Rs 21 Cr
Net sales (latest year)Rs 22 Cr
Sales (latest quarter)Rs 5 Cr
Operating profit excl. other income (latest year)Rs 5 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 5 Cr
PBDT (TTM)Rs 5 Cr
Profit before tax (TTM)Rs 4 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 3 Cr
Net profit (latest year)Rs 3 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 6 Cr
Total expenditure (latest year)Rs 16 Cr
Total income (latest year)Rs 22 Cr
Share capitalRs 4 Cr
ReservesRs 14 Cr
Shareholders' fundsRs 18 Cr
Total assetsRs 26 Cr
Net blockRs 4 Cr
Capital work in progressRs 1 Cr
ReceivablesRs 11 Cr
InventoryRs 5 Cr
Other liabilitiesRs 5 Cr
Shares outstanding (crore)0.37
Ownership
Promoter holding36.44% (+12.19 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 20.6 is at the 40th percentile of its own 7.0-year range (median 24.1, low 8.8, high 201.6).
P/B 3.68 is at the 65th percentile (median 2.01).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period527005Nifty 50Difference
1 week-1.8%-2.8% +0.9 pts
1 month+38.1%-6.8% +44.9 pts
3 months+41.5%-7.6% +49.2 pts
3 years-50.5%+14.2% -64.7 pts
5 years+1528.5%+27.9% +1500.6 pts

Red flags

F-score 6 of 8
explainWeak cash conversion Cash from operations was 40% of net profit over the last 3 years
explainReceivables outrunning sales Receivables grew 60% vs sales +30% in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹5 Cr -8.2% vs Jun 2025. Net profit ₹1 Cr +15.2%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Poly Medicure Ltd16,67152.112.5 %
Molbio Diagnostics Ltd14,47066.618.0 %
Fischer Medical Ventures Ltd2,35596.211.4 %
Tarsons Products Ltd1,7541484.59 %
Q-Line Biotech Ltd1,56927.822.5 %
Laxmi Dental Ltd1,05830.415.0 %
Hemant Surgical Industries Ltd86951.318.9 %
Vasa Denticity Ltd75462.37.54 %
OSEL Devices Ltd69123.624.4 %
Prevest Denpro Ltd46220.524.9 %
QMS Medical Allied Services Ltd41939.012.9 %
Nureca Ltd34980.43.30 %
Aprameya Engineering Ltd20039.712.6 %
Avience Biomedicals Ltd19822.727.0 %
Earkart Limited17936.317.5 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Shree Pacetronix Ltd?

Shree Pacetronix Ltd (527005) has a market capitalisation of Rs 71.2 Cr. at the 2026-10-01 close.

What is the P/E ratio of Shree Pacetronix Ltd?

Shree Pacetronix Ltd trades at a P/E of 22.0 on trailing twelve-month profit, at the 2026-10-01 close.

What were Shree Pacetronix Ltd's latest quarterly results?

In the Jun 2026 quarter, Shree Pacetronix Ltd sales was Rs 5 Cr (-8.2% vs Jun 2025) and net profit was Rs 1 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03